208 related articles for article (PubMed ID: 18207275)
1. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials.
Jung J; Matsuzaki T; Tatematsu K; Okajima T; Tanizawa K; Kuroda S
J Control Release; 2008 Mar; 126(3):255-64. PubMed ID: 18207275
[TBL] [Abstract][Full Text] [Related]
2. Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.
Kasuya T; Jung J; Kinoshita R; Goh Y; Matsuzaki T; Iijima M; Yoshimoto N; Tanizawa K; Kuroda S
Methods Enzymol; 2009; 464():147-66. PubMed ID: 19903554
[TBL] [Abstract][Full Text] [Related]
3. Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.
Jung J; Iijima M; Yoshimoto N; Sasaki M; Niimi T; Tatematsu K; Jeong SY; Choi EK; Tanizawa K; Kuroda S
Protein Expr Purif; 2011 Aug; 78(2):149-55. PubMed ID: 21515381
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.
Yamada M; Oeda A; Jung J; Iijima M; Yoshimoto N; Niimi T; Jeong SY; Choi EK; Tanizawa K; Kuroda S
J Control Release; 2012 Jun; 160(2):322-9. PubMed ID: 22100387
[TBL] [Abstract][Full Text] [Related]
5. Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.
Somiya M; Sasaki Y; Matsuzaki T; Liu Q; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Kuroda S
J Control Release; 2015 Aug; 212():10-8. PubMed ID: 26074149
[TBL] [Abstract][Full Text] [Related]
6. Targeting of polyplex to human hepatic cells by bio-nanocapsules, hepatitis B virus surface antigen L protein particles.
Somiya M; Yoshimoto N; Iijima M; Niimi T; Dewa T; Jung J; Kuroda S
Bioorg Med Chem; 2012 Jun; 20(12):3873-9. PubMed ID: 22591855
[TBL] [Abstract][Full Text] [Related]
7. Construction of arginine-rich peptide displaying bionanocapsules.
Shishido T; Yonezawa D; Iwata K; Tanaka T; Ogino C; Fukuda H; Kondo A
Bioorg Med Chem Lett; 2009 Mar; 19(5):1473-6. PubMed ID: 19200722
[TBL] [Abstract][Full Text] [Related]
8. Complex carriers of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery.
Nishimura Y; Ishii J; Okazaki F; Ogino C; Kondo A
J Drug Target; 2012 Dec; 20(10):897-905. PubMed ID: 23020553
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for the delivery of genes and drugs to human hepatocytes.
Yamada T; Iwasaki Y; Tada H; Iwabuki H; Chuah MK; VandenDriessche T; Fukuda H; Kondo A; Ueda M; Seno M; Tanizawa K; Kuroda S
Nat Biotechnol; 2003 Aug; 21(8):885-90. PubMed ID: 12833071
[TBL] [Abstract][Full Text] [Related]
10. Expression of squamous cell carcinoma antigen-1 in liver enhances the uptake of hepatitis B virus envelope-derived bio-nanocapsules in transgenic rats.
Kasuya T; Nomura S; Matsuzaki T; Jung J; Yamada T; Tatematsu K; Okajima T; Tanizawa K; Kuroda S
FEBS J; 2008 Nov; 275(22):5714-24. PubMed ID: 18959756
[TBL] [Abstract][Full Text] [Related]
11. [Bio-nanocapsules for in vivo pinpoint drug delivery].
Jung J; Kasuya T; Tanizawa K; Kuroda S
Yakugaku Zasshi; 2007 May; 127(5):797-805. PubMed ID: 17473521
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery into hepatocytes with the preS/liposome/DNA system.
Wang Z; Yuan Z; Jin L
Biotechnol J; 2008 Oct; 3(9-10):1286-95. PubMed ID: 18830969
[TBL] [Abstract][Full Text] [Related]
13. Bio-nanocapsules displaying various immunoglobulins as an active targeting-based drug delivery system.
Tatematsu K; Iijima M; Yoshimoto N; Nakai T; Okajima T; Kuroda S
Acta Biomater; 2016 Apr; 35():238-47. PubMed ID: 26876802
[TBL] [Abstract][Full Text] [Related]
14. Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants.
Jung J; Somiya M; Jeong SY; Choi EK; Kuroda S
Nanomedicine; 2018 Feb; 14(2):595-600. PubMed ID: 29175598
[TBL] [Abstract][Full Text] [Related]
15. Protein-encapsulated bio-nanocapsules production with ER membrane localization sequences.
Nishimura Y; Shishido T; Ishii J; Tanaka T; Ogino C; Kondo A
J Biotechnol; 2012 Jan; 157(1):124-9. PubMed ID: 21963589
[TBL] [Abstract][Full Text] [Related]
16. Engineered bio-nanocapsules, the selective vector for drug delivery system.
Yu D; Fukuda T; Tuoya ; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada T; Tada H; Seno M
IUBMB Life; 2006 Jan; 58(1):1-6. PubMed ID: 16596748
[TBL] [Abstract][Full Text] [Related]
17. Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery.
Li H; Tatematsu K; Somiya M; Iijima M; Kuroda S
Acta Biomater; 2018 Jun; 73():412-423. PubMed ID: 29673839
[TBL] [Abstract][Full Text] [Related]
18. A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning.
Percot A; Briane D; Coudert R; Reynier P; Bouchemal N; Lièvre N; Hantz E; Salzmann JL; Cao A
Int J Pharm; 2004 Jun; 278(1):143-63. PubMed ID: 15158957
[TBL] [Abstract][Full Text] [Related]
19. The specific delivery of proteins to human liver cells by engineered bio-nanocapsules.
Yu D; Amano C; Fukuda T; Yamada T; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada H; Tada H; Seno M
FEBS J; 2005 Jul; 272(14):3651-60. PubMed ID: 16008564
[TBL] [Abstract][Full Text] [Related]
20. Electroporation and use of hepatitis B virus envelope L proteins as bionanocapsules.
Yamada T; Jung J; Seno M; Kondo A; Ueda M; Tanizawa K; Kuroda S
Cold Spring Harb Protoc; 2012 Jun; 2012(6):702-5. PubMed ID: 22661433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
